NASDAQ:LYEL

Lyell Immunopharma Stock Predictions

etoro logo Buy LYEL
*Your capital is at risk
$12.57
-2.32 (-15.58%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

LYEL Prediction Chart

LYEL Predictions History

Latest community submissions for LYEL.
Predictor Target Session Target Price Result Direction Accuracy Score
Jul 5, 2023 $3.17 -94.89% $3.08 X 97.07% 0
Jul 5, 2023 $3.06 -95.19% $3.08 V 99.35% 4
JS JS Pro
Jun 30, 2023 $3.13 -95.00% $3.18 V 98.43% 0
Jun 30, 2023 Bullish $3.18 X 1
Jun 30, 2023 $3.25 -94.81% $3.18 X 97.83% 1
Jun 30, 2023 $3.20 -94.88% $3.18 X 99.24% 3
JS JS Pro
Jun 29, 2023 $3.16 -95.05% $3.13 V 99.04% 2
Jun 29, 2023 $3.31 -94.81% $3.13 X 94.16% 0
Jun 29, 2023 $3.11 -95.12% $3.13 V 99.47% 4
JS JS Pro
Jun 28, 2023 $3.28 -94.94% $3.19 X 97.18% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LYEL with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT LYELL IMMUNOPHARMA, INC.
Lyell Immunopharma
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE